Proximal Urethral Carcinoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Proximal Urethral Carcinoma

subtype

Identifier: CI-CAN-00009112
Entity page: /cancer/proximal-urethral-carcinoma ↗
Edges: 19

Neighbours: 10 drugs9 trials
Drawn: 19 of 19 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Proximal Urethral Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived10 of 10
→ investigated in trials for	Gemcitabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Proximal Urethral Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Afatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants

Proximal Urethral Carcinoma studied in …STUDIED_INderived9 of 9
→ studied in	NCT02122172Phase 2 · terminated Afatinib in Advanced Refractory Urothelial Cancer · condition mapped ALIAS · 9 trials mapped (0 active)	—	—	Proximal Urethral Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00478361Phase 2 · completed Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function · condition mapped ALIAS · 9 trials mapped (0 active)	—	—	Proximal Urethral Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT01611662Phase 2 · terminated Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer · condition mapped ALIAS · 9 trials mapped (0 active)	—	—	Proximal Urethral Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00407485Phase 2 · completed VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium · condition mapped ALIAS · 9 trials mapped (0 active)	—	—	Proximal Urethral Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00112905Phase 2 · terminated Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium · condition mapped ALIAS · 9 trials mapped (0 active)	—	—	Proximal Urethral Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00471536Phase 2 · completed Pazopanib in Treating Patients With Metastatic Urothelial Cancer · condition mapped ALIAS · 9 trials mapped (0 active)	—	—	Proximal Urethral Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00004856Phase 2 · terminated Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium · condition mapped ALIAS · 9 trials mapped (0 active)	—	—	Proximal Urethral Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped ALIAS · 9 trials mapped (0 active)	—	—	Proximal Urethral Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00021099Phase 2 · completed Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer · condition mapped ALIAS · 9 trials mapped (0 active)	—	—	Proximal Urethral Carcinoma	1	Observed	clinicaltrials	graph →